Comparions the Effect of Different Treatment Modalities on Chronic Plantar Fasiitis
The Comparison of the Effects of ESWT and Instrument Assisted Soft Tissue Mobilization Techniques in the Treatment of Chronic Plantar Fasiitis- Randomized Controlled Trial
1 other identifier
interventional
63
1 country
1
Brief Summary
Plantar fasciitis is a common cause of heel pain affecting about 20% of the general population. The basic treatment of plantar fasciitis is conservative. Approximately 85-90% of plantar fasciitis patients can be successfully treated without surgery. Methods include resting, nonsteroidal anti-inflammatory drugs, stretching, shoe orthotics, corticosteroid injections, physical therapy, night splints, and extracorporeal shock wave therapy (ESWT) and ultrasound therapy. Plantar fasciitis treatment is a chronic treatment that has been clearly described in the literature despite the use of treatment modalities. In the literature, treatment modalities which should be used respectively in the treatment of plantar fasciitis are expressed. Nevertheless, it is a chronic disease caused by skipping the treatment steps for various reasons or applying the treatments in the wrong hierarchy. The aim of this project is to compare the effects of stretching exercises, ESWT and instrument-assisted myofascial relaxation technique (Graston Technique®) in the treatment of chronic plantar fasciitis in terms of pain, disability level, quality of life and static and dynamic plantar pressure analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Dec 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 27, 2018
CompletedFirst Submitted
Initial submission to the registry
June 10, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2020
CompletedFirst Posted
Study publicly available on registry
March 26, 2020
CompletedMarch 26, 2020
March 1, 2020
1.1 years
June 10, 2019
March 25, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
First step pain: Visuel Analog Scale (VAS)
Visuel Analog Scale by using 10 cm likert scale.
Changes in the VAS scores of the three groups before the treatment.
First step pain: Visuel Analog Scale (VAS)
Visuel Analog Scale by using 10 cm likert scale.
Changes in the VAS scores of the three groups 4 weeks after treatment.
First step pain: Visuel Analog Scale (VAS)
Visuel Analog Scale by using 10 cm likert scale.
Changes in the VAS scores of the three groups 8 weeks after treatment.
Secondary Outcomes (6)
Pressure Pain Threshold
Changes in the pressure pain threshold (mean value of three measurement) of the three groups before and 4 weeks after treatment and at 8 weeks will be compared.
Kinesiophobia
Changes in the Tampa scores of the three groups before and 4 weeks after treatment and at 8 weeks will be compared.
Foot Function Index
Changes in the Foot function Index scores of the three groups before and 4 weeks after treatment and at 8 weeks will be compared.
SF-12
Pre-intervention, 5th weeks (post-intervention) and 8th weeks.
Plantar Pressure Analysis
Changes in the VAChanges in the Plantar Pressure Analysis of the three groups before and 4 weeks after treatment and at 8 weeks will be compared.
- +1 more secondary outcomes
Study Arms (3)
ESWT Group
EXPERIMENTALPatients in the ESWT group will be treated with ESWT once a week for 4 weeks. Each patient was treated with epine calcaneus and its surroundings. The treatment dose of 10 Hz, 2.5 bar, 2000 shock wave with BTL L-6000 SWT device will be applied by the same therapist. Patient completed plantar fascia and gastrocnemius streching exercises right after treatment. The patient completed the plantar fascia and gastrocnemius stretching exercises right after treatment and also continue at home for 4 weeks, 2 sets per day. Completed 3 repetation for each exercise and stayed in the same position for 30 seconds.
Graston Technique® Group
EXPERIMENTALThe application was carried out by Graston Technique® (GT®) certified, a therapist with orthopedic rehabilitation and soft tissue treatments for over 12 years. GT® instruments were used to diagnose and treat the damaged soft tissue of gastrocnemius and plantar fascia. The application protocol and the instruments used according to the regions were determined with reference to the GT® manual. GT® treatment can be given to the same region twice a week. A minimum of 2 days break was given between the applications. Gastrocnemius and plantar fascia application completed in 5 minutes in one leg. GT2, GT4 and GT6 instruments used for application.The patient completed the plantar fascia and gastrocnemius stretching exercises right after treatment and also continue at home for 4 weeks, 2 sets per day. Completed 3 repetation for each exercise and stayed in the same position for 30 seconds.
Control Group
EXPERIMENTALStretching group was accepted as the control group. the patient monitored once a week at the hospital and continue home stretching program at home. These patients will be given information about plantar fasciitis as well as other groups. Plantar fascia and gastrosoleus self-stretching exercises will be required to be performed twice a day for thirty seconds and three repetitions for 4 weeks. The patients will be followed with an exercise follow-up form.
Interventions
The treatment period for each group was determined as 4 weeks. Stretching program for each group will be given as home exercise program. Stretching exercises will be completed in 3 sets, 2 sets per day, stretching for 30 seconds. Graston Technique Group will take treatment 2 times per week, ESWT group will take treatment 1 time per week.
Eligibility Criteria
You may qualify if:
- diagnosis with plantar fasciitis, between age o 18-60 and have pain for more than 3 months,
- patients with at least 3 conservative treatments were unsuccessful (include usage of anti-inflammatory drugs, cortisone injection and surgical),
- according to Visual Analogue Scale (VAS), patients with (VAS)≥5
You may not qualify if:
- calcaneal fracture and implants,
- tarsal tunnel syndrome,
- infection,
- neurological problems,
- tumor,
- coagulated impairments,
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pelin Pişirici
Istanbul, Beşiktaş/İstanbul, 34353, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pelin Pişirici, PT, PhD
Medipol University Institute of Health Sciences
- STUDY DIRECTOR
Dilber Karagozoglu Coskunsu, PT, PhD
Bahçeşehir University Faculty of Health Sciences
- STUDY CHAIR
Feryal Subaşı, PT, Prof
Yeditepe University Faculty of Health Sciences
- STUDY CHAIR
Uğur Şaylı, MD. Prof.
Yeditepe University Hospital
- STUDY CHAIR
Elif Tugce Cil, PT, MSc
Yeditepe University Faculty of Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- There is blind assessor who has 20 year experienced PhD PT. Participants are also blinded.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PT, PHD (c), Lecturer
Study Record Dates
First Submitted
June 10, 2019
First Posted
March 26, 2020
Study Start
December 27, 2018
Primary Completion
January 30, 2020
Study Completion
March 1, 2020
Last Updated
March 26, 2020
Record last verified: 2020-03